These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 38767413)

  • 1. CHD2 Regulates Neuron-Glioma Interactions in Pediatric Glioma.
    Zhang X; Duan S; Apostolou PE; Wu X; Watanabe J; Gallitto M; Barron T; Taylor KR; Woo PJ; Hua X; Zhou H; Wei HJ; McQuillan N; Kang KD; Friedman GK; Canoll PD; Chang K; Wu CC; Hashizume R; Vakoc CR; Monje M; McKhann GM; Gogos JA; Zhang Z
    Cancer Discov; 2024 Sep; 14(9):1732-1754. PubMed ID: 38767413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptomic and epigenetic profiling of 'diffuse midline gliomas, H3 K27M-mutant' discriminate two subgroups based on the type of histone H3 mutated and not supratentorial or infratentorial location.
    Castel D; Philippe C; Kergrohen T; Sill M; Merlevede J; Barret E; Puget S; Sainte-Rose C; Kramm CM; Jones C; Varlet P; Pfister SM; Grill J; Jones DTW; Debily MA
    Acta Neuropathol Commun; 2018 Nov; 6(1):117. PubMed ID: 30396367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenome Programming by H3.3K27M Mutation Creates a Dependence of Pediatric Glioma on SMARCA4.
    Mo Y; Duan S; Zhang X; Hua X; Zhou H; Wei HJ; Watanabe J; McQuillan N; Su Z; Gu W; Wu CC; Vakoc CR; Hashizume R; Chang K; Zhang Z
    Cancer Discov; 2022 Dec; 12(12):2906-2929. PubMed ID: 36305747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmaco-proteogenomic profiling of pediatric diffuse midline glioma to inform future treatment strategies.
    Findlay IJ; De Iuliis GN; Duchatel RJ; Jackson ER; Vitanza NA; Cain JE; Waszak SM; Dun MD
    Oncogene; 2022 Jan; 41(4):461-475. PubMed ID: 34759345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ACVR1 R206H cooperates with H3.1K27M in promoting diffuse intrinsic pontine glioma pathogenesis.
    Hoeman CM; Cordero FJ; Hu G; Misuraca K; Romero MM; Cardona HJ; Nazarian J; Hashizume R; McLendon R; Yu P; Procissi D; Gadd S; Becher OJ
    Nat Commun; 2019 Mar; 10(1):1023. PubMed ID: 30833574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic targeting of prenatal pontine ID1 signaling in diffuse midline glioma.
    Messinger D; Harris MK; Cummings JR; Thomas C; Yang T; Sweha SR; Woo R; Siddaway R; Burkert M; Stallard S; Qin T; Mullan B; Siada R; Ravindran R; Niculcea M; Dowling AR; Bradin J; Ginn KF; Gener MAH; Dorris K; Vitanza NA; Schmidt SV; Spitzer J; Li J; Filbin MG; Cao X; Castro MG; Lowenstein PR; Mody R; Chinnaiyan A; Desprez PY; McAllister S; Dun MD; Hawkins C; Waszak SM; Venneti S; Koschmann C; Yadav VN
    Neuro Oncol; 2023 Jan; 25(1):54-67. PubMed ID: 35605606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated analyses reveal two molecularly and clinically distinct subtypes of H3 K27M-mutant diffuse midline gliomas with prognostic significance.
    Stegat L; Eckhardt A; Gocke A; Neyazi S; Pohl L; Schmid S; Dottermusch M; Frank S; Pinnschmidt H; Herms J; Glatzel M; Snuderl M; Schweizer L; Thomas C; Neumann J; Dorostkar MM; Schüller U; Wefers AK
    Acta Neuropathol; 2024 Sep; 148(1):40. PubMed ID: 39256213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual targeting of histone deacetylases and MYC as potential treatment strategy for H3-K27M pediatric gliomas.
    Algranati D; Oren R; Dassa B; Fellus-Alyagor L; Plotnikov A; Barr H; Harmelin A; London N; Ron G; Furth N; Shema E
    Elife; 2024 Aug; 13():. PubMed ID: 39093942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new subtype of diffuse midline glioma, H3 K27 and BRAF/FGFR1 co-altered: a clinico-radiological and histomolecular characterisation.
    Auffret L; Ajlil Y; Tauziède-Espariat A; Kergrohen T; Puiseux C; Riffaud L; Blouin P; Bertozzi AI; Leblond P; Blomgren K; Froelich S; Picca A; Touat M; Sanson M; Beccaria K; Blauwblomme T; Dangouloff-Ros V; Boddaert N; Varlet P; Debily MA; Grill J; Castel D
    Acta Neuropathol; 2023 Dec; 147(1):2. PubMed ID: 38066305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncohistones and disrupted development in pediatric-type diffuse high-grade glioma.
    Ocasio JK; Budd KM; Roach JT; Andrews JM; Baker SJ
    Cancer Metastasis Rev; 2023 Jun; 42(2):367-388. PubMed ID: 37119408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adult diffuse midline gliomas: Clinical, radiological, and genetic characteristics.
    Dono A; Takayasu T; Ballester LY; Esquenazi Y
    J Clin Neurosci; 2020 Dec; 82(Pt A):1-8. PubMed ID: 33317715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diffuse hemispheric glioma with H3 p.K28M (K27M) mutation: Unusual non-midline presentation of diffuse midline glioma, H3 K27M-altered?
    Donev K; Sundararajan V; Johnson D; Balan J; Chambers M; Paulson VA; Scherpelz KP; Abdullaev Z; Quezado M; Cimino PJ; Pratt D; Valerio E; Alves de Castro JV; Carraro DM; Torrezan GT; Wolff BM; Kulikowski LD; Costa FD; Aldape K; Ida CM
    J Neuropathol Exp Neurol; 2024 Apr; 83(5):357-364. PubMed ID: 38447592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histone H3K27 methylation modulates the dynamics of FANCD2 on chromatin to facilitate NHEJ and genome stability.
    Zhang Y; Chang JF; Sun J; Chen L; Yang XM; Tang HY; Jing YY; Kang X; He ZM; Wu JY; Wei HM; Wang DL; Xu RG; Zhu RB; Shen Y; Zeng SY; Wang C; Liu KN; Zhang Y; Mao ZY; Jiang CZ; Sun FL
    J Cell Sci; 2018 Jun; 131(12):. PubMed ID: 29760279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the reprogrammed metabolism in H3.3K27M pediatric high-grade gliomas.
    de Camargo Magalhães ES; de Bont ESJM; Bruggeman SWM; Lima FRS
    Biochim Biophys Acta Mol Basis Dis; 2024 Aug; 1870(6):167248. PubMed ID: 38777100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histone H3 K27M-mediated regulation of cancer cell stemness and differentiation in diffuse midline glioma.
    Sharma M; Barravecchia I; Magnuson B; Ferris SF; Apfelbaum A; Mbah NE; Cruz J; Krishnamoorthy V; Teis R; Kauss M; Koschmann C; Lyssiotis CA; Ljungman M; Galban S
    Neoplasia; 2023 Oct; 44():100931. PubMed ID: 37647805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholinergic Neuronal Activity Promotes Diffuse Midline Glioma Growth through Muscarinic Signaling.
    Drexler R; Drinnenberg A; Gavish A; Yalcin B; Shamardani K; Rogers A; Mancusi R; Taylor KR; Kim YS; Woo PJ; Ravel A; Tatlock E; Ramakrishnan C; Ayala-Sarmiento AE; Pacheco DRF; Siverts L; Daigle TL; Tasic B; Zeng H; Breunig JJ; Deisseroth K; Monje M
    bioRxiv; 2024 Sep; ():. PubMed ID: 39386427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of current therapeutics targeting the mitochondrial protease ClpP in diffuse midline glioma, H3 K27-altered.
    Jackson ER; Persson ML; Fish CJ; Findlay IJ; Mueller S; Nazarian J; Hulleman E; van der Lugt J; Duchatel RJ; Dun MD
    Neuro Oncol; 2024 May; 26(Supplement_2):S136-S154. PubMed ID: 37589388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting neuronal activity-regulated neuroligin-3 dependency in high-grade glioma.
    Venkatesh HS; Tam LT; Woo PJ; Lennon J; Nagaraja S; Gillespie SM; Ni J; Duveau DY; Morris PJ; Zhao JJ; Thomas CJ; Monje M
    Nature; 2017 Sep; 549(7673):533-537. PubMed ID: 28959975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histone H3.3K27M Mobilizes Multiple Cancer/Testis (CT) Antigens in Pediatric Glioma.
    Deng H; Zeng J; Zhang T; Gong L; Zhang H; Cheung E; Jones C; Li G
    Mol Cancer Res; 2018 Apr; 16(4):623-633. PubMed ID: 29453317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Standardization of the liquid biopsy for pediatric diffuse midline glioma using ddPCR.
    Li D; Bonner ER; Wierzbicki K; Panditharatna E; Huang T; Lulla R; Mueller S; Koschmann C; Nazarian J; Saratsis AM
    Sci Rep; 2021 Mar; 11(1):5098. PubMed ID: 33658570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.